Altox

Database / API & reference standards

API & reference standards

Afatinib

Afatinib is listed in the API and reference-standard collection under CAS 850140-72-6. Its represented structure has formula C24H25ClFN5O3 and a calculated molecular weight of 485.95 g/mol.

2D chemical structure

N O N H H N F C l N N O O ( S ) ( E )

Chemical identity

Catalog name
Afatinib
Common name
Afatinib
Chemical name
(E)-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamide
CAS
850140-72-6
SMILES
CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1
InChI
InChI=1S/C24H25ClFN5O3/c1-31(2)8-3-4-23(32)30-21-11-17-20(12-22(21)34-16-7-9-33-13-16)27-14-28-24(17)29-15-5-6-19(26)18(25)10-15/h3-6,10-12,14,16H,7-9,13H2,1-2H3,(H,30,32)(H,27,28,29)/b4-3+/t16-/m0/s1
InChIKey
ULXXDDBFHOBEHA-CWDCEQMOSA-N
Associated API
Afatinib

Record ID: Ac652c249d905

Computed properties

C24H25ClFN5O3 Molecular formula
485.947 g/molMolecular weight
485.163 DaMonoisotopic exact mass
88.61 ŲTopological polar surface area
4.3899 Calculated LogP (Wildman–Crippen)
130.4064 cm³/molMolar refractivity (Wildman–Crippen)
7 countHydrogen-bond acceptors
2 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 3 6 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C Cl F H N O 0 6 12 18 24 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight485.94783.69
Calculated LogP (Wildman–Crippen)4.389983.43
Topological polar surface area88.6164.47
Hydrogen-bond acceptors783.12
Hydrogen-bond donors264.87
Rotatable bonds (strict)882.26

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC24H25ClFN5O3dimensionless
Molecular weight485.947g/mol
Monoisotopic exact mass485.163Da
Topological polar surface area88.61Ų
Calculated LogP (Wildman–Crippen)4.3899dimensionless
Molar refractivity (Wildman–Crippen)130.4064cm³/mol
Hydrogen-bond acceptors7count
Hydrogen-bond donors2count
Rotatable bonds (strict)8count
Heavy atoms34count
Heteroatoms10count
Rings4count
Aromatic rings3count
Aliphatic rings1count
Saturated rings1count
Aromatic heterocycles1count
Aliphatic heterocycles1count
Saturated heterocycles1count
Aromatic carbocycles2count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms0.2917fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters1count
Unspecified atom stereocenters0count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area201.2804Ų
Valence electrons178count
Radical electrons0count
Bertz complexity1,214.6778index
Balaban J1.6803index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for Afatinib

PDE, HBEL and impurity assessment for Afatinib

For a substance-specific assessment, request a PDE report for Afatinib or explore HBEL derivation for Afatinib. These services address exposure limits using toxicological evidence and the intended use of the substance.

For pharmaceutical development, explore prediction of degradation products of Afatinib and qualification of impurities related to Afatinib.

Related Altox services and technical resources

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for Afatinib

Explore Altox services and software through the Altox Pharma-Hub.